These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 28803245
1. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer. He M, Zhan M, Chen W, Xu S, Long M, Shen H, Shi Y, Liu Q, Mohan M, Wang J. Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245 [Abstract] [Full Text] [Related]
2. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Shu YJ, Bao RF, Jiang L, Wang Z, Wang XA, Zhang F, Liang HB, Li HF, Ye YY, Xiang SS, Weng H, Wu XS, Li ML, Hu YP, Lu W, Zhang YJ, Zhu J, Dong P, Liu YB. Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377 [Abstract] [Full Text] [Related]
3. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Zhang M, Gong W, Zuo B, Chu B, Tang Z, Zhang Y, Yang Y, Zhou D, Weng M, Qin Y, Ma M, Jiang A, Ma F, Quan Z. Oncotarget; 2016 Nov 29; 7(48):78640-78652. PubMed ID: 27769047 [Abstract] [Full Text] [Related]
4. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. Dai M, Chen N, Li J, Tan L, Li X, Wen J, Lei L, Guo D. Phytomedicine; 2021 Jul 29; 87():153580. PubMed ID: 34029939 [Abstract] [Full Text] [Related]
5. MiR-20a triggers metastasis of gallbladder carcinoma. Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J, Hu L, Li L, Jiang F, Chen C, Wang R, Yang Y, Jiang X, Wu M, Chen L, Wang H. J Hepatol; 2013 Sep 29; 59(3):518-27. PubMed ID: 23665284 [Abstract] [Full Text] [Related]
6. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression. Zhang X, Zhang L, Chen M, Liu D. Artif Cells Nanomed Biotechnol; 2020 Dec 29; 48(1):315-324. PubMed ID: 31858815 [Abstract] [Full Text] [Related]
7. The microRNA cluster miR-214/miR-3120 prevents tumor cell switching from an epithelial to a mesenchymal-like phenotype and inhibits autophagy in gallbladder cancer. Li W, Yan P, Meng X, Zhang J, Yang Y. Cell Signal; 2021 Apr 29; 80():109887. PubMed ID: 33340658 [Abstract] [Full Text] [Related]
8. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma. Bao RF, Shu YJ, Hu YP, Wang XA, Zhang F, Liang HB, Ye YY, Li HF, Xiang SS, Weng H, Cao Y, Wu XS, Li ML, Wu WG, Zhang YJ, Jiang L, Dong Q, Liu YB. Oncotarget; 2016 Apr 19; 7(16):22339-54. PubMed ID: 26968949 [Abstract] [Full Text] [Related]
9. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138. Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C, Wang J, Chen E, Quan Z. Open Biol; 2017 Jan 19; 7(1):. PubMed ID: 28077595 [Abstract] [Full Text] [Related]
10. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3. Chen SY, Teng SC, Cheng TH, Wu KJ. Cancer Lett; 2016 Aug 01; 378(1):59-67. PubMed ID: 27177472 [Abstract] [Full Text] [Related]
11. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p. Liu XF, Wang K, Du HC. Eur Rev Med Pharmacol Sci; 2020 Jul 01; 24(14):7598-7611. PubMed ID: 32744686 [Abstract] [Full Text] [Related]
12. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7. Ye YY, Mei JW, Xiang SS, Li HF, Ma Q, Song XL, Wang Z, Zhang YC, Liu YC, Jin YP, Hu YP, Jiang L, Liu FT, Zhang YJ, Hao YJ, Liu YB. Cell Death Dis; 2018 Mar 14; 9(3):410. PubMed ID: 29540696 [Abstract] [Full Text] [Related]
13. microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression. Peng D, Wu T, Wang J, Huang J, Zheng L, Wang P, Li J, Wu L, Luo M. Chem Biol Interact; 2022 Mar 01; 355():109780. PubMed ID: 34990588 [Abstract] [Full Text] [Related]
14. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D, Quan ZW. Tumour Biol; 2016 Jul 01; 37(7):9721-30. PubMed ID: 26803515 [Abstract] [Full Text] [Related]
15. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2. Lv ZD, Yang DX, Liu XP, Jin LY, Wang XG, Yang ZC, Liu D, Zhao JJ, Kong B, Li FN, Wang HB. Cell Physiol Biochem; 2017 Jul 01; 44(5):1785-1795. PubMed ID: 29216628 [Abstract] [Full Text] [Related]
16. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2. Li XL, Li SZ, Wu CX, Xing XH. Kaohsiung J Med Sci; 2021 Apr 01; 37(4):294-304. PubMed ID: 33236530 [Abstract] [Full Text] [Related]
17. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer. Cheng CW, Chen PM, Hsieh YH, Weng CC, Chang CW, Yao CC, Hu LY, Wu PE, Shen CY. Oncotarget; 2015 Dec 29; 6(42):44222-38. PubMed ID: 26528854 [Abstract] [Full Text] [Related]
18. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma. Li CF, Li YC, Wang Y, Sun LB. Cell Physiol Biochem; 2018 Dec 29; 50(1):196-213. PubMed ID: 30278464 [Abstract] [Full Text] [Related]
19. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma. Tan H, Zhao L. J Cell Biochem; 2019 Apr 29; 120(4):6502-6514. PubMed ID: 30485482 [Abstract] [Full Text] [Related]
20. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer. Chen K, Ye J, Qi L, Liao Y, Li R, Song S, Zhou C, Feng R, Zhai W. Anticancer Drugs; 2019 Oct 29; 30(9):925-932. PubMed ID: 31517732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]